Dossier · Private startup · 1 independent source
Eleos Health
Last updated: Jul 31, 2026
Eleos Health provides a behavioral-health-specific AI platform for community-based care organizations. Its software turns session and operational signals into documentation, compliance, clinical-insight, and revenue-cycle actions while keeping clinicians responsible for final decisions.
Visit WebsiteCompany Overview
Eleos Health is a privately held Israel-founded, U.S.-headquartered healthcare software company focused on the operational layer of behavioral health and community-based care. Its current positioning is broader than an ambient note-writing assistant: Eleos describes a "system of action" that captures clinical and operational signals and applies them to documentation, compliance, clinical insights, eligibility, and revenue-cycle workflows. The company says its purpose-built Polaris AI is designed for behavioral-health and substance-use-disorder settings rather than being a general medical model adapted after the fact.
The customer problem is unusually concrete. Community providers face high documentation workloads, staff shortages, payer-specific rules, audit exposure, and thin operating margins. Eleos combines ambient or text-based documentation, automated review of every note before sign-off, configurable quality and payer checks, eligibility and revenue-cycle support, and clinical insights around risk, crisis, evidence-based practice, substance use disorder, and CCBHC workflows. The company reports that more than 200 organizations and 25,000 clinicians use the platform in 2026; those are company-reported adoption figures, but they indicate a meaningful move beyond prototype validation. Its 2025 Series C announcement reported more than 120 customer organizations in over 30 states, more than $120 million in total funding, and a push into additional behavioral-health segments.
Commercially, Eleos sits at the intersection of ambient documentation, clinical analytics, compliance automation, and healthcare revenue-cycle tooling. Competitors range from behavioral-health specialists such as Lyssn and Blueprint to broad ambient-AI vendors such as Abridge and Ambience Healthcare, plus incumbent behavioral-health information systems and EHR vendors such as Netsmart and Qualifacts. Eleos's proposed moat is workflow depth and domain data: behavioral-health-specific note structures, terminology, payer and program rules, integrations, implementation know-how, and accumulated feedback from real sessions. That specialization may improve accuracy and switching costs, but it also narrows the market and leaves the company exposed to general-purpose models, EHR feature expansion, and platform bundling.
The strongest commercial case depends on independently validating more than time saved. Diligence should test retention and net expansion, implementation effort, gross margin after customer success, the share of notes and claims processed, denial reduction, audit outcomes, and whether clinical-insight features change care or merely generate additional alerts. Buyers will also scrutinize patient consent, recording and retention controls, model evaluation by population and language, human review, EHR interoperability, and the division of responsibility when generated text or risk signals are wrong. Eleos's own materials describe external security testing and clinician review, but those statements should be checked against current contracts, audit reports, and customer references.
Defense and national-security relevance is limited and indirect. The underlying capabilities could support veteran care, military-family behavioral health, public-sector crisis programs, or other regulated care networks where documentation quality, privacy, and auditability matter. That does not make Eleos a defense platform: there is no verified defense product, military contract, or mission-specific security application in the evidence reviewed. Its strategic relevance is therefore as a case study in trusted automation for sensitive workflows, not as a direct security asset.
Strategic Fit Assessment
Priority signal means this entry may be worth researching within the Claw & Talon thesis. It does not mean investable, suitable, endorsed, available, or likely to produce returns.
Eleos is a credible growth-stage healthcare software startup with a focused wedge, a broader platform roadmap, a reported Series C, and reported adoption across hundreds of provider organizations. Its relevance to this database is strongest as trusted automation in a sensitive, compliance-heavy domain, not as a defense-native opportunity. Key diligence gates are evidence of durable retention, measurable reimbursement and clinical impact, secure data governance, and sustainable differentiation as EHRs and general-purpose AI vendors add ambient documentation.
Strategic Value to U.S.-Israel Alliance
Eleos demonstrates how domain-specific AI can be embedded in PHI-heavy workflows where human approval, auditability, payer rules, and operational integration matter. That is strategically relevant to a thesis around reliable automation in sensitive systems. The company offers little direct national-security capability, however, so its strategic value is illustrative and adjacent rather than mission-critical.
Key Technologies
- Audio-native speech recognition and behavioral-health NLP
- Polaris AI for structured clinical and operational signal extraction
- Ambient and text-assisted clinical documentation generation
- Configurable compliance and quality rules applied before note sign-off
- Eligibility and revenue-cycle automation for claims workflows
- Clinical-insight agents for risk, crisis, SUD, and evidence-based practice signals
- EHR-agnostic web workflow and secure PHI processing
Use Cases & Applications
- Ambient psychotherapy, psychiatry, group, and SUD documentation
- Pre-submission note quality, payer-rule, and compliance checks
- Eligibility verification and claim denial prevention
- Clinical supervision, quality assurance, and audit prioritization
- Real-time support for crisis, risk, evidence-based practice, and CCBHC workflows
- Multi-site community-provider operations and care-at-home analytics
- Veteran and military-family behavioral-health administration
- Public-sector behavioral-health programs requiring auditable human-in-the-loop automation
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work; the research methodology documents how evidence is graded, what counts as an independent source, and why some profiles are excluded from search indexing.
This record lists 6 public references used for company identity, status, positioning, or material-claim review.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- eleos.health Public source used for profile verification.
- eleos.health Public source used for profile verification.
- eleos.health Public source used for profile verification.
- eleos.health Public source used for profile verification.
- LinkedIn company page Public source used for profile verification.
- statnews.com Public source used for profile verification.
- Profile update timestamp Last updated in the Claw & Talon database on Jul 31, 2026.
Related sector
See the Health & BioTech sector page for market context, related subcategories, and other Israeli companies in this part of the database.